Cargando…
Twenty-first Century Governance Challenges in the Life Sciences
The chapter explores the rapid advancement of biotechnology over the past few decades, outlining an array of factors that drive innovation and, at the same time, raise concerns about the extent to which the scope and pace of novel life science developments can be adequately governed. From ‘dual-use...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416832/ http://dx.doi.org/10.1007/978-3-319-51004-0_4 |
_version_ | 1783569370287439872 |
---|---|
author | Novossiolova, Tatyana |
author_facet | Novossiolova, Tatyana |
author_sort | Novossiolova, Tatyana |
collection | PubMed |
description | The chapter explores the rapid advancement of biotechnology over the past few decades, outlining an array of factors that drive innovation and, at the same time, raise concerns about the extent to which the scope and pace of novel life science developments can be adequately governed. From ‘dual-use life science research of concern’ through the rise of amateur biology to the advent of personalised medicine, the chapter exposes the limitations of the existing governance mechanisms in accommodating the multifaceted ethical, social, security, and legal concerns arising from cutting-edge scientific and technological developments. |
format | Online Article Text |
id | pubmed-7416832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-74168322020-08-11 Twenty-first Century Governance Challenges in the Life Sciences Novossiolova, Tatyana Governance of Biotechnology in Post-Soviet Russia Article The chapter explores the rapid advancement of biotechnology over the past few decades, outlining an array of factors that drive innovation and, at the same time, raise concerns about the extent to which the scope and pace of novel life science developments can be adequately governed. From ‘dual-use life science research of concern’ through the rise of amateur biology to the advent of personalised medicine, the chapter exposes the limitations of the existing governance mechanisms in accommodating the multifaceted ethical, social, security, and legal concerns arising from cutting-edge scientific and technological developments. 2016-11-29 /pmc/articles/PMC7416832/ http://dx.doi.org/10.1007/978-3-319-51004-0_4 Text en © The Author(s) 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Novossiolova, Tatyana Twenty-first Century Governance Challenges in the Life Sciences |
title | Twenty-first Century Governance Challenges in the Life Sciences |
title_full | Twenty-first Century Governance Challenges in the Life Sciences |
title_fullStr | Twenty-first Century Governance Challenges in the Life Sciences |
title_full_unstemmed | Twenty-first Century Governance Challenges in the Life Sciences |
title_short | Twenty-first Century Governance Challenges in the Life Sciences |
title_sort | twenty-first century governance challenges in the life sciences |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416832/ http://dx.doi.org/10.1007/978-3-319-51004-0_4 |
work_keys_str_mv | AT novossiolovatatyana twentyfirstcenturygovernancechallengesinthelifesciences |